<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Wang X</submitter><pubmed_abstract>Cognitive impairments are generally observed in patients with schizophrenia. However, it is unclear whether neurocognitive dysfunction can predict the efficacy of antipsychotics for first-episode schizophrenia (FES). Machine learning methods provide a relatively unbiased approach when evaluating heterogeneous data, especially when building multifactor prediction models. This study conducted a secondary analysis based on the Chinese FES Trial (CNFEST), which was a 1-year study involving a randomized controlled trial for the first eight weeks followed by a 48-week open-label observation. The current study aimed to build a prediction model of eight-week antipsychotic response based on baseline clinical and demographic features. Six machine learning algorithms, including random forest, eXtreme</pubmed_abstract><journal>Schizophrenia (Heidelberg, Germany)</journal><pagination>105</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12284124</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Neurocognition as a major predictor of 8-week response to antipsychotics for drug-naive first-episode schizophrenia using machine learning.</pubmed_title><pmcid>PMC12284124</pmcid><pubmed_authors>Yin X</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Hu W</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Ji Y</pubmed_authors><pubmed_authors>Huang B</pubmed_authors><pubmed_authors>Pu C</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><pubmed_authors>Gao T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neurocognition as a major predictor of 8-week response to antipsychotics for drug-naive first-episode schizophrenia using machine learning.</name><description>Cognitive impairments are generally observed in patients with schizophrenia. However, it is unclear whether neurocognitive dysfunction can predict the efficacy of antipsychotics for first-episode schizophrenia (FES). Machine learning methods provide a relatively unbiased approach when evaluating heterogeneous data, especially when building multifactor prediction models. This study conducted a secondary analysis based on the Chinese FES Trial (CNFEST), which was a 1-year study involving a randomized controlled trial for the first eight weeks followed by a 48-week open-label observation. The current study aimed to build a prediction model of eight-week antipsychotic response based on baseline clinical and demographic features. Six machine learning algorithms, including random forest, eXtreme</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-07-15T06:53:16.895Z</modification><creation>2025-08-16T03:05:44.686Z</creation></dates><accession>S-EPMC12284124</accession><cross_references><pubmed>40695829</pubmed><doi>10.1038/s41537-025-00640-y</doi></cross_references></HashMap>